BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26996573)

  • 21. Association between a catechol-o-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population.
    Niehaus DJ; Kinnear CJ; Corfield VA; du Toit PL; van Kradenburg J; Moolman-Smook JC; Weyers JB; Potgieter A; Seedat S; Emsley RA; Knowles JA; Brink PA; Stein DJ
    J Affect Disord; 2001 Jun; 65(1):61-5. PubMed ID: 11426511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder.
    Schindler KM; Richter MA; Kennedy JL; Pato MT; Pato CN
    Am J Med Genet; 2000 Dec; 96(6):721-4. PubMed ID: 11121168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic nervous function and the effect of the catechol-O-methyltransferase Val(158)Met polymorphism in patients with panic disorder.
    Kang EH; Song YJ; Kim KJ; Shim HB; Park JE; Yu BH
    J Affect Disord; 2010 Jun; 123(1-3):337-40. PubMed ID: 19900710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of catechol-O-methyl transferase (COMT) gene -287A/G polymorphism with susceptibility to obsessive-compulsive disorder in Chinese Han population.
    Liu S; Liu Y; Wang H; Zhou R; Zong J; Li C; Zhang X; Ma X
    Am J Med Genet B Neuropsychiatr Genet; 2011 Jun; 156B(4):393-400. PubMed ID: 21344643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COMT Val158Met polymorphism and executive functions in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Öztürk N; Özata B; Ertekin BA; Ertekin E; Baran B; Kalem ŞA; Büyükgök D; Direskeneli GS
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):214-21. PubMed ID: 23774999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association between the COMT Val158Met polymorphism and the long-term clinical response in obsessive-compulsive disorder in the Japanese population.
    Umehara H; Numata S; Tajima A; Kinoshita M; Nakaaki S; Imoto I; Sumitani S; Ohmori T
    Hum Psychopharmacol; 2015 Sep; 30(5):372-6. PubMed ID: 26010653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
    Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMT and MAO-A polymorphisms and obsessive-compulsive disorder: a family-based association study.
    Sampaio AS; Hounie AG; Petribú K; Cappi C; Morais I; Vallada H; do Rosário MC; Stewart SE; Fargeness J; Mathews C; Arnold P; Hanna GL; Richter M; Kennedy J; Fontenelle L; de Bragança Pereira CA; Pauls DL; Miguel EC
    PLoS One; 2015; 10(3):e0119592. PubMed ID: 25793616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of COMT Val158Met polymorphism in Eastern UP population.
    Kumar P; Yadav U; Rai V
    Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):21-24. PubMed ID: 28968204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder.
    Vulink NC; Westenberg HG; van Nieuwerburgh F; Deforce D; Fluitman SB; Meinardi JS; Denys D
    Int J Psychiatry Clin Pract; 2012 Oct; 16(4):277-83. PubMed ID: 22414277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between catechol-O-methyltransferase functional polymorphism and male suicide completers.
    Ono H; Shirakawa O; Nushida H; Ueno Y; Maeda K
    Neuropsychopharmacology; 2004 Jul; 29(7):1374-7. PubMed ID: 15127078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males.
    Denys D; Van Nieuwerburgh F; Deforce D; Westenberg H
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):446-50. PubMed ID: 16427255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
    Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
    J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of catechol-O-methyltransferase Val(108/158) Met genetic polymorphism with schizophrenia, P50 sensory gating, and negative symptoms in a Chinese population.
    Mao Q; Tan YL; Luo XG; Tian L; Wang ZR; Tan SP; Chen S; Yang GG; An HM; Yang FD; Zhang XY
    Psychiatry Res; 2016 Aug; 242():271-276. PubMed ID: 27315458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insight and alexithymia in adult outpatients with obsessive-compulsive disorder.
    De Berardis D; Campanella D; Gambi F; Sepede G; Salini G; Carano A; La Rovere R; Pelusi L; Penna L; Cicconetti A; Cotellessa C; Salerno RM; Ferro FM
    Eur Arch Psychiatry Clin Neurosci; 2005 Oct; 255(5):350-8. PubMed ID: 15711867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
    Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No association between anxiety disorders and catechol-O-methyltransferase polymorphism.
    Ohara K; Nagai M; Suzuki Y; Ochiai M; Ohara K
    Psychiatry Res; 1998 Aug; 80(2):145-8. PubMed ID: 9754693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personality and Alexithymic Disparity in Obsessive-Compulsive Disorder Based on Washing and Checking.
    Tang HS; Chen PF; Lung FW
    Psychiatr Q; 2018 Jun; 89(2):371-381. PubMed ID: 29038990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
    Gothelf D; Michaelovsky E; Frisch A; Zohar AH; Presburger G; Burg M; Aviram-Goldring A; Frydman M; Yeshaya J; Shohat M; Korostishevsky M; Apter A; Weizman A
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):301-8. PubMed ID: 16734939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced 3-O-methyl-dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele.
    Delorme R; Betancur C; Chaste P; Kernéis S; Stopin A; Mouren MC; Collet C; Bourgeron T; Leboyer M; Launay JM
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):542-548. PubMed ID: 19676096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.